home All News open_in_new Full Article

‘Patients will suffer’: tales from the frontline of the UK pharma crisis

The pricing standoff between government and industry has stalled research and put thousands of jobs at risk‘We want to see more investment flow to Britain,” the chancellor, Rachel Reeves, urged of big pharmaceutical companies this month, as she indicated that the government was willing to increase the price it pays for NHS drugs. Ministers are likely to announce a rethink on pricing soon, potentially by the end of this week.But the size of that rise remains uncertain. The big question is whether it will be generous enough to convince pharmaceutical companies, which account for a near-£100bn slice of the UK economy, to resume the investments they had paused in a strong-arm campaign to secure concessions from government. Continue reading...


today 3 w. ago attach_file Science

attach_file Politics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Sport
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Society
attach_file Politics
attach_file Events
attach_file Events
attach_file Sport
attach_file Economics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 2889025261
Add Watch Country

arrow_drop_down